Crystal Pharmatech Co., Ltd.

Crystal Pharmatech, a global leader in solid-state research and formulation development, today highlights its First-Time-Right Formulation approach designed with full lifecycle intent for small-molecule drug programs.

New Suzhou facility complements existing U.S. infrastructure, delivering dual-continent containment capabilities for high-potency API programs